NewsAug 29, 2026
If your dermatomyositis keeps flaring through steroids and other immunosuppressants, there's finally a pill for it. Lisraya, approved on August 27, 2026, is the first oral drug ever cleared for this disease, and a randomized trial shows it quiets skin, restores function, and lets people cut their steroid dose at the same time. The label is narrow, the boxed warning is serious, and the list price runs about $35,000 a month. So it's not for milder or already well-controlled disease. For the patient whose disease keeps winning, though, this is a live new choice.
Thyroid HealthJun 2, 2026
Most doctors check TSH at annual physicals and call thyroid function normal if it falls within the broad reference range of 0.4-4.0 mIU/L. But TSH is a pituitary hormone, not a thyroid hormone. It reflects what the pituitary thinks the thyroid should be doing, not necessarily what the thyroid is actually accomplishing. Millions of people have thyroid symptoms with normal TSH because they have central hypothyroidism, thyroid hormone conversion problems, or early autoimmune thyroid disease that TSH screening misses entirely.
Autoimmune DiseaseMay 31, 2026
Celiac disease masquerades as dozens of other conditions. Chronic fatigue, joint pain, headaches, digestive issues, skin problems, and even neurological symptoms can all stem from this autoimmune reaction to gluten. The average time from symptom onset to diagnosis is still 6-10 years in many countries, partly because symptoms are so variable and partly because testing approaches often miss the condition entirely. Modern celiac testing is highly accurate when done correctly, but the details matter enormously.
